136 related articles for article (PubMed ID: 24855987)
21. Synthesis and characterization of novel dipeptide ester prodrugs of acyclovir.
Nashed YE; Mitra AK
Spectrochim Acta A Mol Biomol Spectrosc; 2003 Jul; 59(9):2033-9. PubMed ID: 12788456
[TBL] [Abstract][Full Text] [Related]
22. Successful kinase bypass with new acyclovir phosphoramidate prodrugs.
McGuigan C; Derudas M; Bugert JJ; Andrei G; Snoeck R; Balzarini J
Bioorg Med Chem Lett; 2008 Aug; 18(15):4364-7. PubMed ID: 18614365
[TBL] [Abstract][Full Text] [Related]
23. Novel water-soluble prodrugs of acyclovir cleavable by the dipeptidyl-peptidase IV (DPP IV/CD26) enzyme.
Diez-Torrubia A; Cabrera S; de Castro S; García-Aparicio C; Mulder G; De Meester I; Camarasa MJ; Balzarini J; Velázquez S
Eur J Med Chem; 2013; 70():456-68. PubMed ID: 24185376
[TBL] [Abstract][Full Text] [Related]
24. Tailoring acyclovir prodrugs with enhanced antiviral activity: rational design, synthesis, human plasma stability and in vitro evaluation.
Chayrov RL; Stylos EK; Chatziathanasiadou MV; Chuchkov KN; Tencheva AI; Kostagianni AD; Milkova TS; Angelova AL; Galabov AS; Shishkov SA; Todorov DG; Tzakos AG; Stankova IG
Amino Acids; 2018 Aug; 50(8):1131-1143. PubMed ID: 29779181
[TBL] [Abstract][Full Text] [Related]
25. Amino acid prodrugs of acyclovir as possible antiviral agents against ocular HSV-1 infections: interactions with the neutral and cationic amino acid transporter on the corneal epithelium.
Anand BS; Katragadda S; Nashed YE; Mitra AK
Curr Eye Res; 2004; 29(2-3):153-66. PubMed ID: 15512962
[TBL] [Abstract][Full Text] [Related]
26. The physicochemical properties, plasma enzymatic hydrolysis, and nasal absorption of acyclovir and its 2'-ester prodrugs.
Shao Z; Park GB; Krishnamoorthy R; Mitra AK
Pharm Res; 1994 Feb; 11(2):237-42. PubMed ID: 8165182
[TBL] [Abstract][Full Text] [Related]
27. Investigation of lipophilicity of anticancer-active thioquinoline derivatives.
Bajda M; Boryczka S; Wietrzyk J; Malawska B
Biomed Chromatogr; 2007 Feb; 21(2):123-31. PubMed ID: 17120300
[TBL] [Abstract][Full Text] [Related]
28. Lipophilic Studies and In Silico ADME Profiling of Biologically Active 2-Aminothiazol-4(5
Redka M; Baumgart S; Kupczyk D; Kosmalski T; Studzińska R
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569606
[TBL] [Abstract][Full Text] [Related]
29. Transport of acyclovir ester prodrugs through rabbit cornea and SIRC-rabbit corneal epithelial cell line.
Tak RV; Pal D; Gao H; Dey S; Mitra AK
J Pharm Sci; 2001 Oct; 90(10):1505-15. PubMed ID: 11745709
[TBL] [Abstract][Full Text] [Related]
30. Effect of acylation on the ocular disposition of acyclovir. I: Synthesis, physicochemical properties, and antiviral activity of 2'-esters.
Hughes PM; Krishnamoorthy R; Mitra AK
J Ocul Pharmacol; 1993; 9(4):287-97. PubMed ID: 8106835
[TBL] [Abstract][Full Text] [Related]
31. Review of research leading to new anti-herpesvirus agents in clinical development: valaciclovir hydrochloride (256U, the L-valyl ester of acyclovir) and 882C, a specific agent for varicella zoster virus.
Purifoy DJ; Beauchamp LM; de Miranda P; Ertl P; Lacey S; Roberts G; Rahim SG; Darby G; Krenitsky TA; Powell KL
J Med Virol; 1993; Suppl 1():139-45. PubMed ID: 8245881
[TBL] [Abstract][Full Text] [Related]
32. Novel dipeptide prodrugs of acyclovir for ocular herpes infections: Bioreversion, antiviral activity and transport across rabbit cornea.
Anand B; Nashed Y; Mitra A
Curr Eye Res; 2003; 26(3-4):151-63. PubMed ID: 12815543
[TBL] [Abstract][Full Text] [Related]
33. Nonpolymeric nanoassemblies for ocular administration of acyclovir: pharmacokinetic evaluation in rabbits.
Stella B; Arpicco S; Rocco F; Burgalassi S; Nicosia N; Tampucci S; Chetoni P; Cattel L
Eur J Pharm Biopharm; 2012 Jan; 80(1):39-45. PubMed ID: 22008147
[TBL] [Abstract][Full Text] [Related]
34. Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPT1 cells overexpressing a human peptide transporter.
Han HK; Oh DM; Amidon GL
Pharm Res; 1998 Sep; 15(9):1382-6. PubMed ID: 9755889
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and evaluation of amino acid esters of 6-deoxypenciclovir as potential prodrugs of penciclovir.
Kim DK; Lee N; Kim YW; Chang K; Im GJ; Choi WS; Kim KH
Bioorg Med Chem; 1999 Feb; 7(2):419-24. PubMed ID: 10218837
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, chemical and enzymatic hydrolysis, and bioavailability evaluation in rabbits of metronidazole amino acid ester prodrugs with enhanced water solubility.
Mahfouz NM; Hassan MA
J Pharm Pharmacol; 2001 Jun; 53(6):841-8. PubMed ID: 11428660
[TBL] [Abstract][Full Text] [Related]
37. Improved industrial syntheses of penciclovir and famciclovir using N2-acetyl-7-benzylguanine and a cyclic side chain precursor.
Torii T; Yamashita K; Kojima M; Suzuki Y; Hijiya T; Izawa K
Nucleosides Nucleotides Nucleic Acids; 2006; 25(4-6):625-34. PubMed ID: 16838850
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and anti-VZV activity of 6-heteroaryl derivatives of tricyclic acyclovir and 9-{[cis-1',2'-bis(hydroxymethyl)cycloprop-1'-yl]methyl}guanine analogues.
Ostrowski T; Golankiewicz B; De Clercq E; Andrei G; Snoeck R
Eur J Med Chem; 2009 Aug; 44(8):3313-7. PubMed ID: 19339082
[TBL] [Abstract][Full Text] [Related]
39. Cyclopropanecarboxylic acid esters as potential prodrugs with enhanced hydrolytic stability.
Bender DM; Peterson JA; McCarthy JR; Gunaydin H; Takano Y; Houk KN
Org Lett; 2008 Feb; 10(3):509-11. PubMed ID: 18181639
[TBL] [Abstract][Full Text] [Related]
40. Preparation and in vitro antiviral activity of liposomes of lipophilic esters of acyclovir.
Tong P; Hou XP; Shao S; Zhang YM; Zhang CH
Yao Xue Xue Bao; 1992; 27(1):15-21. PubMed ID: 1326852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
